tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Omeros announces publication of narsoplimab survival outcomes in TA-TMA

Omeros (OMER) announced the publication of a peer-reviewed manuscript in the American Journal of Hematology detailing survival outcomes in patients with transplant-associated thrombotic microangiopathy treated with narsoplimab. The data is from a global expanded access program and reports outcomes in patients treated with narsoplimab as a first-line therapy and in those who failed prior treatments. A biologics license application for narsoplimab in TA-TMA is currently under review by the FDA.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1